# Vetanic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vetanic

- Industry: Biotechnology
- Headquarters: Tokyo, Japan
- Website: www.vetanic.com
- Total disclosed funding: $5M
- Latest round: Series B (Aug 24, 2022)
- Investors on record: 2

## About

Based in Tokyo, Japan, Vetanic Inc. is dedicated to advancing animal regenerative medicine through innovative solutions using induced pluripotent stem (iPS) cell technology for veterinary applications.Founded in 2021, Vetanic Inc. focuses on animal regenerative medicine. The firm has received two rounds of funding, with the latest being a Series B round on August 24, 2022, raising JPY 500 million from Keio Innovation Initiative and QB Capital. The company is led by Akinori Mochizuki, who serves as both the CEO and Founder.Vetanic specializes in animal regenerative medicine, focusing on the development and application of iPS cell technology. Their offerings include generating canine iPS cells and differentiating them into canine mesenchymal stem cells (MSCs) for regenerative medical products. These products address health issues in companion animals, particularly dogs, and are validated through research with leading institutions.Vetanic operates by commercializing regenerative medical products derived from their proprietary iPS cell technology. Revenue is generated through partnerships with veterinary clinics and research institutions, utilizing licensing agreements for their technology and selling developed regenerative products, including custom therapies for individual animals.Vetanic plans to utilize the JPY 500 million raised in the Series B financing for research, development, clinical trials, manufacturing, and product expansion. The company aims to introduce new regenerative medical products while expanding into wider markets beyond Japan as regulatory approvals are secured.

## Funding rounds

- Series B, Aug 24, 2022, $3.6M — Keio Innovation Initiative, QB Capital
- Series A, Jul 15, 2021, $1.4M — Keio Innovation Initiative, QB Capital

## Investors

- Keio Innovation Initiative (https://capitalatlas.ai/funds/keio-innovation-initiative) — Series A, Series B
- QB Capital (https://capitalatlas.ai/funds/qb-capital) — Series A, Series B